| Financial Year |
March 31 2023 |
| Monetary Funds |
55,966,655.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,539,236.67 |
| Accounts Receivable |
260,475,864.98 |
| Advances to Suppliers |
9,510,136.62 |
| Other Receivables |
2,316,875.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
234,094,033.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
139,198.48 |
| Total Current Assets |
663,501,075.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
24,170,034.15 |
| Fixed Assetes |
334,829,693.14 |
| Under-construction Projects |
31,030,214.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,082,870.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,219,135.90 |
| Deferred Income Tax Assets |
21,730,153.35 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
490,018,982.82 |
| Total Assets |
1,153,520,057.89 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,141,806.28 |
| Accounts Payable |
48,503,946.80 |
| Accounts Received In Advance |
633,492.69 |
| Employee Compensation Payable |
12,623,643.46 |
| Taxes Payable |
2,595,183.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,867,799.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,609,174.31 |
| Other Current Liabilities |
2,164,526.31 |
| Sub-Total of Current Liabilities |
198,789,775.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,284,566.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,796,029.14 |
| Total Liabilities |
241,585,804.38 |
| Paid-In Capital(Or Share Stock) |
340,000,000.00 |
| Capital Surplus |
302,393,628.56 |
| Surplus Reserve |
21,534,073.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
222,310,976.06 |
| Minority Stockholder's Interest |
14,457,686.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
897,476,566.83 |
| Owner's Equity（Stockholder's Equity） |
911,934,253.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,153,520,057.89 |
